| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
61,456,000 |
| Market
Cap: |
799.54(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.9 - $16.15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
41,629 |
106,345 |
| Total Sell Value |
$0 |
$0 |
$382,438 |
$1,585,048 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
10 |
21 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Colon Grace |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,181 |
4,181 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
312 |
64,109 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
468 |
94,463 |
|
- |
|
| Goldberg Michael |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
734 |
88,893 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2019-07-01 |
4 |
AS |
$35.74 |
$341,045 |
D/D |
(9,542) |
48,335 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2019-07-01 |
4 |
OE |
$1.00 |
$250 |
D/D |
250 |
57,877 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2019-07-01 |
4 |
AS |
$35.65 |
$712,936 |
D/D |
(20,000) |
42,045 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2019-07-01 |
4 |
OE |
$2.30 |
$45,713 |
D/D |
19,875 |
62,045 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2019-06-20 |
4 |
AS |
$38.38 |
$1,183,513 |
D/D |
(30,840) |
57,627 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2019-06-20 |
4 |
OE |
$1.00 |
$169,816 |
D/D |
16,195 |
88,467 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2019-06-20 |
4 |
AS |
$38.81 |
$570,601 |
D/D |
(14,702) |
70,900 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2019-06-20 |
4 |
OE |
$1.00 |
$161,594 |
D/D |
14,702 |
85,602 |
|
- |
|
| Hagstrom William A |
Director |
– • – |
2019-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,613 |
27,885 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2019-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,613 |
93,995 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2019-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,613 |
63,797 |
|
- |
|
| Goldberg Michael |
Director |
– • – |
2019-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,613 |
88,159 |
|
- |
|
| Cohen Fred E |
Director |
– • – |
2019-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
2,613 |
55,514 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
AS |
$37.54 |
$750,876 |
D/D |
(20,000) |
42,170 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2019-06-17 |
4 |
OE |
$6.49 |
$129,800 |
D/D |
20,000 |
62,170 |
|
- |
|
| Hagstrom William A |
Director |
– • – |
2019-06-04 |
4 |
S |
$32.35 |
$485,250 |
D/D |
(15,000) |
25,272 |
|
- |
|
| Maag Peter |
Chief Executive Officer |
• • – |
2019-06-03 |
4 |
D |
$32.80 |
$609,818 |
D/D |
(18,592) |
389,814 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2019-06-03 |
4 |
D |
$32.80 |
$40,639 |
D/D |
(1,239) |
42,170 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2019-06-03 |
4 |
D |
$32.80 |
$203,262 |
D/D |
(6,197) |
70,900 |
|
- |
|
| King Sasha |
Chief Commercial Officer |
• – – |
2019-06-03 |
4 |
D |
$32.80 |
$141,762 |
D/D |
(4,322) |
72,272 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2019-05-20 |
4 |
AS |
$32.10 |
$70,694 |
D/D |
(2,202) |
77,097 |
|
- |
|
783 Records found
|
|
Page 18 of 32 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.51 (3.77%) 
